Pharma BD Deal Intelligence

Allergan plc / Zeltiq Aesthetics, Inc.

2017 · Acquisition/Merger · $2.5B · Complete

Allergan agreed to acquire Zeltiq Aesthetics for $56.50/share in cash, total enterprise value approximately $2.47B. The deal added the FDA-cleared CoolSculpting System to Allergan's medical aesthetics platform as a third pillar alongside facial aesthetics and breast/regenerative medicine. Closed April 28, 2017.

Did it work? Outcome assessment

Assessment window: 5yr post-close.

Key facts

• Announced Feb 13, 2017
• Closed Apr 28, 2017
• Deal value $2.5B
• Deal type Acquisition/Merger
• Therapeutic area Body contouring (non-invasive fat reduction)
• Indications Body contouring (non-invasive fat reduction)
• Key assets CoolSculpting System
• Mechanism Cryolipolysis (controlled cooling)

← Browse all deals  ·  How we score deals